Evidence map›Paper›PMID 32733920›Full record

ArticleFrontiers in cardiovascular medicine2020

Circulating microRNA-133a in Patients With Arterial Hypertension, Hypertensive Heart Disease, and Left Ventricular Diastolic Dysfunction.

Sergiy M Koval, Iryna O Snihurska, Kostiantyn O Yushko, Olga V Mysnychenko, Marina Yu Penkova, Olga M Lytvynova, Alexander E Berezin, Vadym S Lytvynov

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cardiovascular medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Observational
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sergiy M KovalDepartment of Arterial Hypertension and Prevention of Its Complications, Government Institution "L.T. Malaya Therapy National Institute of the National Academy of Medical Science of Ukraine, " Kharkiv, Ukraine.
Iryna O SnihurskaDepartment of Arterial Hypertension and Prevention of Its Complications, Government Institution "L.T. Malaya Therapy National Institute of the National Academy of Medical Science of Ukraine, " Kharkiv, Ukraine.
Kostiantyn O YushkoDepartment of Arterial Hypertension and Prevention of Its Complications, Government Institution "L.T. Malaya Therapy National Institute of the National Academy of Medical Science of Ukraine, " Kharkiv, Ukraine.
Olga V MysnychenkoDepartment of Arterial Hypertension and Prevention of Its Complications, Government Institution "L.T. Malaya Therapy National Institute of the National Academy of Medical Science of Ukraine, " Kharkiv, Ukraine.
Marina Yu PenkovaDepartment of Arterial Hypertension and Prevention of Its Complications, Government Institution "L.T. Malaya Therapy National Institute of the National Academy of Medical Science of Ukraine, " Kharkiv, Ukraine.
Olga M LytvynovaDepartment of Laboratory Diagnostics, National University of Pharmacy, Kharkiv, Ukraine.
Alexander E BerezinInternal Medicine Department, Zaporizhia State Medical University, Zaporizhzhia, Ukraine.
Vadym S LytvynovDepartment of Therapy, Rheumatology and Clinical Pharmacology, Kharkiv Medical Academy of Postgraduate Education (KhMAPE), Kharkiv, Ukraine.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

arterial hypertensionepigeneticshypertensive heart diseaseleft ventricular diastolic dysfunctionmicroRNA-133a

Identifiers

PMID32733920
PMCPMC7358430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.